Pharmacokinetics and effect on blood pressure of doxazosin in normal subjects and patients with renal failure. 1986

R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman

The antihypertensive efficacy and pharmacokinetics of a single 1 mg oral dose of doxazosin were investigated in five healthy male volunteers, six patients with renal failure not on hemodialysis, and four patients with end-stage renal failure studied between two hemodialyses. The dialyzability of doxazosin was studied in five patients. The maximum fall in blood pressure of both volunteers and patients occurred between 4 and 8 hours. In four of five volunteers the blood pressure had returned to baseline within 10 to 12 hours, whereas in the patients with renal failure it took as long as 72 hours. Maximum plasma concentrations were reached in 2.6 to 3.6 hours. The mean AUC did not differ significantly between the groups. The mean (SE) elimination t1/2 was 12.6 hours (3.3) in the volunteers and 13.3 hours (1.8) in the patients with renal insufficiency (not significant). Doxazosin was not appreciably dialyzable.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
December 1986, The New Zealand medical journal,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
January 1980, The Journal of antimicrobial chemotherapy,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
December 1977, Antimicrobial agents and chemotherapy,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
January 1984, Journal of cardiovascular pharmacology,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
November 1973, The Journal of infectious diseases,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
August 1974, Clinical pharmacology and therapeutics,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
November 1974, Postgraduate medical journal,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
January 1986, British journal of clinical pharmacology,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
November 1983, Fukuoka igaku zasshi = Hukuoka acta medica,
R V Carlson, and R R Bailey, and E J Begg, and M G Cowlishaw, and J R Sharman
October 1979, La Nouvelle presse medicale,
Copied contents to your clipboard!